Intra-Uterine Contraceptive Devices Market Professional Analysis on Industry Trends 2025 – Bayer, Teva Pharmaceuticals, DKT International, OCON Medical, MedWOW, Medicines360, Allergan, Agile Therapeutics

The report on “Global Intra-Uterine Contraceptive Devices Market” is a professional report which provides thorough knowledge along with complete information pertaining to the Drone Analytics industry a propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc.

The Global Intra-Uterine Contraceptive Devices Market 2018 to 2025 renders deep perception of the key regional market status of the Drone Analytics Industry on a global level that primarily aims the core regions which comprises of continents like North America, Europe, Asia-Pacific, South America, Rest of the World.

Global Intra-Uterine Contraceptive Devices Market By Product Type (Copper IUCD, Hormonal IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 5289.17 million by 2025, at a CAGR of 4.1% during the forecast period of 2018 to 2025.

Download PDF Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

Global Intra-Uterine Contraceptive Devices Market

Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly economical, effective, and safe birth control devices. Their major role is that they prevent pregnancy for a long period of time and prevent the chances of ectopic pregnancy. They are considered to be 99.0% effective in preventing pregnancy. There are two types of intrauterine devices copper-releasing intrauterine devices and progesterone-releasing intrauterine devices. Copper-releasing intrauterine device works by releasing copper. This copper enhances the inflammatory reaction in the uterus which prevents fertilization of eggs. Progesterone-releasing intrauterine device works by releasing progestin, which thickens the cervical mucus and creates the barrier to sperms.

In 2016, The U.S. Food and Drug Administration pharms approved Bayer AG’s low dose levonorgestrel-releasing intrauterine system. It marketed in the United States under the brand name KyleenaTM. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine system for up to five years. This is very effective protection against pregnancy, using the smallest T-shaped body available today.

Allergan in 2016 launched single-handed Liletta IUD inserter.

To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com

Key Questions Answered in Global Intra-Uterine Contraceptive Devices Market Report:-

Our Report offers:-

• What will the market growth rate, Overview and Analysis by Type of Global Intra-Uterine Contraceptive Devices Market in 2025?

• What are the key factors driving, Analysis by Applications and Countries Global Intra-Uterine Contraceptive Devices Market?

• What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global Intra-Uterine Contraceptive Devices Market?

• Who are Opportunities, Risk and Driving Force of Global Intra-Uterine Contraceptive Devices Market?

• Who are the opportunities and threats faced by the vendors in Global Intra-Uterine Contraceptive Devices Market? Business Overview by Type, Applications, Gross Margin and Market Share

• What are the Global Intra-Uterine Contraceptive Devices Market opportunities, market risk and market overview of the Market?

Segmentation: Global Intra-Uterine Contraceptive Devices Market

The global market for intra-uterine contraceptive devices by the following sub-categories is
presented

By Product Type

• Copper IUCD
• Hormonal IUCD

By End-User

• Hospitals
• Gynecology Clinics
• Community Healthcare

By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

To Buy Complete Report Click Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market

FACTORS DRIVING GROWTH IN THE GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET

The increased rate of unplanned pregnancies:

The rate of unintended pregnancy is increasing year after year, and the government initiatives regarding birth control and use of intra-uterine contraceptive devices in on the rise.

In 2010, at least 36.0% of pregnancies in every United States were unintended. In 2011, nearly half (45.0% or 2.8 million) of the 6.1 million pregnancies in the United States were unintended. In 2011, there were 45 the rate of unintended pregnancies was 45 per 1,000 women in an aged group between 15years –44years. According to a journal published by the lancet global health, 15·6 million abortions (14·1 million–17·3 million) occurred in India in 2015. The rate of abortion was 47 per 1000 women. 3.4 million Abortion occur in health facilities (22.0%). 11.5 million abortion abortions were done through medication (73.0%), 2.2 million abortions were surgical (14.0%).
According to national center for biotechnology information, in 2012 there were 85 million reported pregnancies, out of which 40.0% of all pregnancies were unintended. Of these, 50.0% ended in abortion, 13.0% ended in miscarriage, and 38.0% resulted in an unplanned birth.

Some of the major market players in this market are –

Bayer AG, Teva Pharmaceutical Industries Ltd, Mona Lisa N.V., DKT INTERNATIONAL, OCON Medical Ltd, Pregna International Limited, MedWOW Global, SMB Corporation of India, Meril Life Sciences Pvt. Ltd, GYNEAS, Melbea Innovations, Meril Life Sciences Pvt. Ltd, Melbea AG, Medicines360, ALLERGAN, Agile therapeutics Inc. among others.

Key Reasons to Purchase:

• To gain insightful analyses of the market and have comprehensive understanding of the Global Intra-Uterine Contraceptive Devices Market and its commercial landscape.

• Assess the Intra-Uterine Contraceptive Devices production processes, major issues, and solutions to mitigate the development risk.

• To understand the most affecting driving and restraining forces in the Intra-Uterine Contraceptive Devices Market and its impact in the Global market.

• Learn about the market strategies that are being adopted by leading respective organizations.

• To understand the future outlook and prospects for Global Intra-Uterine Contraceptive Devices Market.

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-intra-uterine-contraceptive-devices-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.